Managing Director, KLIFO GmbH

Dr. Christoph Kapitza joined KLIFO on 1 August 2022 and brings more than 25 years of research experience in the development of drugs, devices and drug-device combination products. He has a proven track record of successfully executing drug development strategies and has held several leadership positions in the pharma industry. Dr. Kapitza has been Principle Investigator in approx. 90 early and later phase studies, and he has been a consultant in relation to clinical development plans (phase I through to post-marketing studies) for several top global pharma companies.

Direct/mobile: +49 160 765 1092
Email: moc.ofilk@aztipaK.hpotsirhC